In addition, the outcomes of network pharmacology and docking calculations showed the affinity of oxo-dihydroxy octadecenoic acid and trihydroxy octadecenoic acid against aldose reductase, PPAR-α, DPP-IV, and α-glucosidase enzymes, which suggests the pharmacological potential of A. pyramidalis phytochemicals against type 2 diabetes. The gene discussed is PPARA; the disease is type 2 diabetes mellitus.